Differential effects of cross-sex hormonal treatment on plasma asymmetric dimethylarginine (ADMA) in healthy male-to-female and female-to-male transsexuals

Atherosclerosis

Volumn 206, Issue 1, 2009, Pages 245-250

  Bunck, Mathijs C ^a   Giltay, Erik J ^b   Diamant, Michaela ^a   Gooren, Louis J ^a   Teerlink, Tom ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amino acids; Asymmetric dimethylarginine; Sex hormones; Transsexuals

Indexed keywords

AMINO ACID; ANTIANDROGEN; CYPROTERONE ACETATE; DIANE; ESTRADIOL; ESTROGEN; N(G),N(G) DIMETHYLARGININE; SEX HORMONE; TESTOSTERONE ESTER;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FEMALE TO MALE TRANSSEXUAL; HORMONAL THERAPY; HORMONE DETERMINATION; HUMAN; HUMAN EXPERIMENT; MALE; MALE TO FEMALE TRANSSEXUAL; NORMAL HUMAN; OPEN STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRANSSEXUALISM;

ADULT; AMINO ACIDS; ANDROGEN ANTAGONISTS; ARGININE; CYPROTERONE ACETATE; ESTRADIOL; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; TESTOSTERONE; TRANSSEXUALISM;

EID: 68949196775     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.01.020     Document Type: Article

References (30)

1. Mendelsohn M.E., and Karas R.H. Molecular and cellular basis of cardiovascular gender differences. Science 308 (2005) 1583-1587
2. Liu P.Y., Death A.K., and Handelsman D.J. Androgens and cardiovascular disease. Endocr Rev 24 (2003) 313-340
3. Wu F.C., and von Eckardstein A. Androgens and coronary artery disease. Endocr Rev 24 (2003) 183-217
4. Bhasin S., and Herbst K. Testosterone and atherosclerosis progression in men. Diabetes Care 26 (2003) 1929-1931
5. Moncada S., and Higgs E.A. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 147 (2006) S193-S201
6. Teerlink T. ADMA metabolism and clearance. Vasc Med 10 (2005) S73-S81
7. Siroen M.P., Teerlink T., Nijveldt R.J., et al. The clinical significance of asymmetric dimethylarginine. Annu Rev Nutr 26 (2006) 203-228
8. Post M.S., Verhoeven M.O., van der Mooren M.J., et al. Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women. J Clin Endocrinol Metab 88 (2003) 4221-4226
9. Teerlink T., Neele S.J., de Jong S., Netelenbos J.C., and Stehouwer CD. Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women. Clin Sci 105 (2003) 67-71
10. Verhoeven M.O., Hemelaar M., van der Mooren M.J., Kenemans P., and Teerlink T. Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo-controlled study. J Intern Med 259 (2006) 199-208
11. Holden D.P., Cartwright J.E., Nussey S.S., and Whitley G.S. Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine. Circulation 108 (2003) 1575-1580
12. Cakir E., Ozcan O., Yaman H., et al. Elevated plasma concentration of asymmetric dimethylarginine that is reduced by single dose testosterone administration in idiopathic hypogonadotropic hypogonadism patients. J Clin Endocrinol Metab 90 (2005) 1651-1654
13. Leifke E., Kinzel M., Tsikas D., et al. Effects of normalization of plasma testosterone levels in hypogonadal men on plasma levels and urinary excretion of asymmetric dimethylarginine (ADMA). Horm Metab Res 40 (2008) 56-59
14. Giltay E.J., Hoogeveen E.K., Elbers J.M., et al. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J Clin Endocrinol Metab 83 (1998) 550-553
15. Elbers J.M., Giltay E.J., Teerlink T., et al. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol (Oxf) 58 (2003) 562-571
16. Teerlink T., Nijveldt R.J., de Jong S., and van Leeuwen P.A. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303 (2002) 131-137
17. de Jong S., and Teerlink T. Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column. Anal Biochem 353 (2006) 287-289
18. Teerlink T., van Leeuwen P.A., and Houdijk A.P. Plasma amino acids determined by liquid chromatography within 17 min. Clin Chem 40 (1994) 245-249
19. Juonala M., Viikari J.S., Alfthan G., et al. Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young finns study. Circulation 116 (2007) 1367-1373
20. Teerlink T. HPLC analysis of ADMA and other methylated L-arginine analogs in biological fluids. J Chromatogr B 851 (2007) 21-29
21. Schulze F., Maas R., Freese R., et al. Determination of a reference value for N N-dimethyl-L-arginine in 500 subjects. Eur J Clin Invest 35 (2005) 622-626
22. Charitidou C., Farmakiotis D., Zournatzi V., et al. The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome. Atherosclerosis 196 (2008) 958-965
23. Tipton K.D. Gender differences in protein metabolism. Curr Opin Clin Nutr Metab Care 4 (2001) 493-498
24. Herbst K.L., and Bhasin S. Testosterone action on skeletal muscle. Curr Opin Clin Nutr Metab Care 7 (2004) 271-277
25. Bhasin S., Calof O.M., Storer T.W., et al. Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab 2 (2006) 146-159
26. Ferrando A.A., Tipton K.D., Doyle D., et al. Testosterone injection stimulates net protein synthesis but not tissue amino acid transport. Am J Physiol 275 (1998) E864-E871
27. Franke W.W., and Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 43 (1997) 1262-1279
28. Cynober L.A. Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition 18 (2002) 761-766
29. Eid H.M.A., Reims H., Arnesen H., et al. Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia. Metabolism 56 (2007) 464-469
30. Marcovecchio M.L., Widmer B., Dunger D.B., and Dalton R.N. Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes. Clin Sci 115 (2008) 361-369